Experimental drug for advanced solid tumors
Part of Cancer clinical trials.
This study tests an experimental drug called QLS5132 for people with advanced solid tumors (cancers that start in organs or tissues). The drug targets a protein called CLDN6 on some cancer cells and might help stop the tumor from growing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer (a solid tumor that has spread or cannot be surgically removed).
- Your cancer can be measured on scans (using standard criteria).
- You are physically able to do light activities (ECOG score 0 or 1).
- Your organs (like liver, kidneys, and heart) are working well enough based on blood tests.
- You have recovered from side effects of previous cancer treatments (except hair loss and mild nerve damage).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called QLS5133 for people with advanced solid tumors (cancers that have spread). The drug may help shrink tumors or slow their growth. The study is in two phases to find the right dose and see how well it works.
This Phase 1 trial tests the safety and how the medicine works in the body, and also looks at early signs of effectiveness. It is for adults with advanced solid tumors, and for Phase 1b specifically, the tumor must show a marker called GPC3.
This trial tests a new combination of drugs for advanced solid tumors. It may help if your cancer has not responded to other treatments, and the goal is to see how safe and effective this new approach is.
This study tests an investigational drug called QLM2011 for people with advanced or metastatic solid tumors that have not responded to standard treatments or for which no standard treatment exists. The goal is to see if the drug is safe and effective.
This trial tests an experimental drug, QLS-1304, for people with advanced solid tumors that have stopped responding to standard treatment. The goal is to see if the drug is safe and effective.
This trial tests a new drug called QLC5508, given in combination with other treatments, for people with advanced solid tumors that have stopped responding to standard therapy or who haven't had treatment yet. The goal is to see if the combination can shrink tumors or slow their growth.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.